These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17458149)

  • 21. Gout in 2006: the perfect storm.
    Terkeltaub R
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "switch-off" mechanism of spontaneous resolution of acute gout attack.
    Marcolongo R; Calabria AA; Lalumera M; Gerli R; Alessandrini C; Cavallo G
    J Rheumatol; 1988 Jan; 15(1):101-9. PubMed ID: 2832599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of uric acid crystal-mediated autoinflammation.
    Martinon F
    Immunol Rev; 2010 Jan; 233(1):218-32. PubMed ID: 20193002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology of gout].
    Milas-Ahić J; Prus V; Visević R
    Reumatizam; 2012; 59(2):89-92. PubMed ID: 23745463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics and experimental models of crystal-induced arthritis. Lessons learned from mice and men: is it crystal clear?
    Reginato AM; Olsen BR
    Curr Opin Rheumatol; 2007 Mar; 19(2):134-45. PubMed ID: 17278928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout.
    Lee JH; Kim HS; Lee JH; Yang G; Kim HJ
    Front Pharmacol; 2022; 13():861399. PubMed ID: 35370689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of hyperuricemia and gouty conditions.
    Bardin T; Richette P
    Curr Opin Rheumatol; 2014 Mar; 26(2):186-91. PubMed ID: 24419750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal-associated arthritis in the elderly.
    Wise CM
    Rheum Dis Clin North Am; 2007 Feb; 33(1):33-55. PubMed ID: 17367691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets.
    Punzi L; Scanu A; Ramonda R; Oliviero F
    Autoimmun Rev; 2012 Nov; 12(1):66-71. PubMed ID: 22884557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent developments in immune activation by uric acid crystals.
    Ng G; Chau EM; Shi Y
    Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):273-7. PubMed ID: 20502971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia.
    Sharon Y; Schlesinger N
    Curr Rheumatol Rep; 2016 Jun; 18(6):37. PubMed ID: 27138165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenesis, diagnostics and therapy of gout].
    Zurek M
    Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEG-uricase in the management of treatment-resistant gout and hyperuricemia.
    Sherman MR; Saifer MG; Perez-Ruiz F
    Adv Drug Deliv Rev; 2008 Jan; 60(1):59-68. PubMed ID: 17826865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of interleukin-1 family members in hyperuricemia and gout.
    Klück V; Liu R; Joosten LAB
    Joint Bone Spine; 2021 Mar; 88(2):105092. PubMed ID: 33129923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gout-induced endothelial impairment: The role of SREBP2 transactivation of YAP.
    Zhao Z; Zhao Y; Zhang Y; Shi W; Li X; Shyy JY; He M; Wang L
    FASEB J; 2021 Jun; 35(6):e21613. PubMed ID: 33977576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why does the gout attack stop? A roadmap for the immune pathogenesis of gout.
    Schett G; Schauer C; Hoffmann M; Herrmann M
    RMD Open; 2015; 1(Suppl 1):e000046. PubMed ID: 26557370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Uric acid and kidneys – Physiological and pathophysiological aspects].
    Kim MJ; Mayr M
    Ther Umsch; 2016; 73(3):167-75. PubMed ID: 27008450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in our understanding of gout as an auto-inflammatory disease.
    Bodofsky S; Merriman TR; Thomas TJ; Schlesinger N
    Semin Arthritis Rheum; 2020 Oct; 50(5):1089-1100. PubMed ID: 32916560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why Does Hyperuricemia Not Necessarily Induce Gout?
    Zhang WZ
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The landscape of pathophysiology guided therapeutic strategies for gout treatment.
    Hao SH; Ye LY; Yang C
    Expert Opin Pharmacother; 2023; 24(18):1993-2003. PubMed ID: 38037803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.